DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Häring HU, Merker L, Seewaldt-Becker E. et al.
EMPA-REG Trial Investigators. Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: A 24-week, randomized, double-blind, placebo-controlled trial.
Diabetes Care 2013;
36: 3396-3404
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.